FI117438B - Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi - Google Patents

Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi Download PDF

Info

Publication number
FI117438B
FI117438B FI971711A FI971711A FI117438B FI 117438 B FI117438 B FI 117438B FI 971711 A FI971711 A FI 971711A FI 971711 A FI971711 A FI 971711A FI 117438 B FI117438 B FI 117438B
Authority
FI
Finland
Prior art keywords
bupivacaine
water
optically enriched
tartaric acid
levobupivacaine
Prior art date
Application number
FI971711A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971711A0 (fi
FI971711A (fi
Inventor
Marianne Langston
Benjamin Mark Skead
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421476A external-priority patent/GB9421476D0/en
Priority claimed from GBGB9504926.8A external-priority patent/GB9504926D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of FI971711A0 publication Critical patent/FI971711A0/fi
Publication of FI971711A publication Critical patent/FI971711A/fi
Application granted granted Critical
Publication of FI117438B publication Critical patent/FI117438B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI971711A 1994-10-25 1997-04-22 Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi FI117438B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9421476 1994-10-25
GB9421476A GB9421476D0 (en) 1994-10-25 1994-10-25 Process and salt
GBGB9504926.8A GB9504926D0 (en) 1995-03-10 1995-03-10 Crystallisation
GB9504926 1995-03-10
PCT/GB1995/002513 WO1996012699A1 (en) 1994-10-25 1995-10-23 Crystallisation of levobupivacaine and analogues thereof
GB9502513 1995-10-23

Publications (3)

Publication Number Publication Date
FI971711A0 FI971711A0 (fi) 1997-04-22
FI971711A FI971711A (fi) 1997-04-22
FI117438B true FI117438B (fi) 2006-10-13

Family

ID=26305863

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971711A FI117438B (fi) 1994-10-25 1997-04-22 Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi

Country Status (16)

Country Link
US (1) US5994548A (da)
EP (1) EP0788480B1 (da)
JP (1) JP3911545B2 (da)
AT (1) ATE245629T1 (da)
AU (1) AU698637B2 (da)
CA (1) CA2200355C (da)
DE (1) DE69531356T2 (da)
DK (1) DK0788480T3 (da)
ES (1) ES2202375T3 (da)
FI (1) FI117438B (da)
HU (1) HU227420B1 (da)
MX (1) MX9703024A (da)
NO (1) NO309266B1 (da)
PL (1) PL183210B1 (da)
PT (1) PT788480E (da)
WO (1) WO1996012699A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
US7094812B2 (en) * 2003-04-24 2006-08-22 Xerox Corporations Colorant compositions
US6790267B1 (en) * 2003-04-24 2004-09-14 Xerox Corporation Colorant compositions
PL1809329T3 (pl) 2004-09-17 2012-08-31 Durect Corp Kompozycja znieczulająca zawierająca saib o przedłużonym uwalnianiu do stosowania miejscowego
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2009535327A (ja) * 2006-04-25 2009-10-01 ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド ロピバカイン塩酸塩無水物およびその調製
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
ES2383714T3 (es) * 2008-01-15 2012-06-25 Pharmathen S.A. Proceso para preparar un compuesto (S)-1-alquil-2',6'-pipecoloxilidídico
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
IL290150B2 (en) * 2016-12-26 2024-03-01 Cellix Bio Private Ltd Compounds and methods for treating chronic pain
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (da) * 1967-05-18 1971-12-27 Sterling Drug Inc
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide

Also Published As

Publication number Publication date
DE69531356D1 (de) 2003-08-28
NO971903L (no) 1997-04-24
FI971711A0 (fi) 1997-04-22
PL183210B1 (pl) 2002-06-28
DE69531356T2 (de) 2004-05-27
CA2200355A1 (en) 1996-05-02
DK0788480T3 (da) 2003-09-29
HU227420B1 (en) 2011-05-30
AU698637B2 (en) 1998-11-05
MX9703024A (es) 1997-10-31
NO309266B1 (no) 2001-01-08
FI971711A (fi) 1997-04-22
PL319829A1 (en) 1997-09-01
JP3911545B2 (ja) 2007-05-09
ATE245629T1 (de) 2003-08-15
NO971903D0 (no) 1997-04-24
HUT77631A (hu) 1998-06-29
EP0788480B1 (en) 2003-07-23
JPH10507464A (ja) 1998-07-21
PT788480E (pt) 2003-12-31
US5994548A (en) 1999-11-30
WO1996012699A1 (en) 1996-05-02
CA2200355C (en) 2007-03-06
AU3704895A (en) 1996-05-15
EP0788480A1 (en) 1997-08-13
ES2202375T3 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
FI117438B (fi) Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi
RU2009128C1 (ru) Гидрохлориды производных 1-бензил-4[(1-инданон)]-метилпиперидина
US20060276654A1 (en) Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
JP4015696B2 (ja) レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法
WO2016038422A1 (en) Process for the preparation of optically enriched adrenaline
AU696875B2 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
US20110065755A1 (en) Stable r(+)-lansoprazole amine salt and a process for preparing the same
DE3625738A1 (de) 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung
US6521792B2 (en) Process for separating the diastereomeric bases of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cylohexanol
DK152752B (da) Fremgangsmaade til fremstilling af l-sulpirid
EP3074397B1 (en) A process for preparation of (2s, 5r)-7-oxo-n-[(2s)-pyrrolidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
DK1988086T4 (da) Fremgangsmåde til opløsning af citalopram via dets (S)-berigede citalopramtartratforbindelse
US20080167470A1 (en) Process of enantiomeric resolution of D,L-(+_)-threo-methylphenidate
KR100472609B1 (ko) 레보부피바카인과그의유사체의결정화벙법
US5929242A (en) Manufacture of levobupivacaine and analogues thereof from L-lysine
JPH1036327A (ja) １−（３−メトキシフェニル）エチルアミンの光学活性体の製造方法
JPS6383056A (ja) ジアステレオマーの分割
JPH08245530A (ja) 光学活性ｔ−ロイシノールの製造方法、４−ｔ−ブチル−２−オキサゾリジノン、オキサゾリン、二環式ラクタム、メルカプトフェニルオキサゾリン、ビスオキサコリンまたはビス（オキサゾリニル）ピリジンの製造方法、医薬または植物保護における有効物質の非対称的合成法および製造方法、および新規化合物
US20080171885A1 (en) Process for Preparation of Highly Pure Trandolapril
EP0434743A4 (en) Methods for preparing captopril and its analogues
JPS61268633A (ja) ラセミ有機アミンの光学分割方法
EP0432204A4 (en) Derivatives and precursors of captopril and its analogues
JPH05255243A (ja) アジリジン−２−カルボン酸誘導体及びその製造方法
MXPA97008494A (en) New process for the preparation of clorhidratode ropivacain monohidrat
HU207831B (en) Process for producing enanthiomere mixtures of nitrogen-containing bases dividing raceme composition

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117438

Country of ref document: FI

MA Patent expired